Potent antibody therapeutics by design
- PMID: 16622479
- DOI: 10.1038/nri1837
Potent antibody therapeutics by design
Abstract
Antibodies constitute the most rapidly growing class of human therapeutics and the second largest class of drugs after vaccines. The generation of potent antibody therapeutics, which I review here, is an iterative design process that involves the generation and optimization of antibodies to improve their clinical potential.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources